• Sponsored Content

BPI Contributor

December 19, 2017

1 Min Read

Short time frames are a major challenge in developing alternative microbiological methods for autologous cell therapy products. Ideally, results are made available in under a day. Obtaining regulatory acceptance also can be a challenge, but it is made easier if methods are included in an application (e.g., a biologics license application, BLA) rather than changing a method that is already part of an approved process. Comparing different detection platforms can be a challenge if they have different readouts, and validation packages are often extensive.

Just fill out the form to view and download the complete eBook.


Get the eBook Now

You May Also Like